An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203753
Company: MYLAN TECHNOLOGIES

Products on ANDA 203753

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SCOPOLAMINE	SCOPOLAMINE	1MG/72HR	SYSTEM;TRANSDERMAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 203753

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/19/2019	ORIG-1	Approval			Review (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/203753Orig1s000ChemR.pdf

Therapeutic Equivalents for ANDA 203753

SCOPOLAMINE

SYSTEM;TRANSDERMAL; 1MG/72HR
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SCOPOLAMINE	SCOPOLAMINE	1MG/72HR	SYSTEM;TRANSDERMAL	Prescription	No	AB	208769	ACTAVIS LABS UT INC
SCOPOLAMINE	SCOPOLAMINE	1MG/72HR	SYSTEM;TRANSDERMAL	Prescription	No	AB	203753	MYLAN TECHNOLOGIES
SCOPOLAMINE	SCOPOLAMINE	1MG/72HR	SYSTEM;TRANSDERMAL	Prescription	No	AB	078830	PADAGIS US
SCOPOLAMINE	SCOPOLAMINE	1MG/72HR	SYSTEM;TRANSDERMAL	Prescription	No	AB	212342	RICONPHARMA LLC
TRANSDERM SCOP	SCOPOLAMINE	1MG/72HR	SYSTEM;TRANSDERMAL	Prescription	Yes	AB	017874	BAXTER HLTHCARE CORP

Top